Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > News > Nanobac Pharmaceuticals, Inc. Announces Confirming Results

February 23rd, 2004

Nanobac Pharmaceuticals, Inc. Announces Confirming Results

Abstract:
Nanobac Pharmaceuticals, Inc. is pleased to announce the publication of independent research which confirms and validates Dr.'s Kajander and Ciftcioglu's findings of the living organism, Nanobacteria Sanguineum, as a causal agent in the formation of kidney stones.

Source:
Businesswire

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Announcements

What heat can tell us about battery chemistry: using the Peltier effect to study lithium-ion cells March 8th, 2024

Curcumin nanoemulsion is tested for treatment of intestinal inflammation: A formulation developed by Brazilian researchers proved effective in tests involving mice March 8th, 2024

The Access to Advanced Health Institute receives up to $12.7 million to develop novel nanoalum adjuvant formulation for better protection against tuberculosis and pandemic influenza March 8th, 2024

Nanoscale CL thermometry with lanthanide-doped heavy-metal oxide in TEM March 8th, 2024

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project